Monica Epperson
Overview
Explore the profile of Monica Epperson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shi J, Gabriel M, Epperson M, Chan P, Jones J, Petersen L, et al.
Microbiol Spectr
. 2025 Feb;
:e0208624.
PMID: 39998388
Numerous studies have investigated vaccine-induced correlates of protection (CoP) against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection, but data on infection-induced CoP are limited. Given differences between vaccine- and infection-induced...
2.
Nguyen K, Relja B, Epperson M, Park S, Thornburg N, Costantini V, et al.
PLoS One
. 2024 Sep;
19(9):e0307936.
PMID: 39226256
mRNA-based COVID-19 vaccines have played a critical role in reducing severe outcomes of COVID-19. Humoral immune responses against SARS-CoV-2 after vaccination have been extensively studied in blood; however, limited information...
3.
Chisty Z, Li D, Haile M, Houston H, DaSilva J, Overton R, et al.
PLoS One
. 2024 Apr;
19(4):e0301367.
PMID: 38625908
Background: Understanding the immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination is important in nursing home (NH) residents, a high-risk population. Methods: An observational longitudinal evaluation of 37 consenting...
4.
Bampoe V, Brown N, Deng L, Schiffer J, Jia L, Epperson M, et al.
Clin Infect Dis
. 2023 Oct;
78(2):470-475.
PMID: 37787062
Background: Tetanus, a life-threatening infection, has become rare in the United States since introduction of tetanus toxoid-containing vaccines (TTCVs), recommended as a childhood series followed by decennial boosters beginning at...
5.
DeJonge P, Lambrou A, Segaloff H, Bateman A, Sterkel A, Griggs C, et al.
BMC Infect Dis
. 2023 Jun;
23(1):374.
PMID: 37277736
Background: University students commonly received COVID-19 vaccinations before returning to U.S. campuses in the Fall of 2021. Given likely immunologic variation among students based on differences in type of primary...
6.
Havers F, Skoff T, Rench M, Epperson M, Rajam G, Schiffer J, et al.
Clin Infect Dis
. 2022 Jun;
76(3):e1087-e1093.
PMID: 35642525
Background: Acellular pertussis (aP) vaccines replaced whole-cell pertussis (wP) vaccines for the US childhood primary series in 1997. As women primed with aP vaccines enter childbearing age, protection of infants...
7.
Bajema K, Dahl R, Evener S, Prill M, Rodriguez-Barradas M, Marconi V, et al.
MMWR Morb Mortal Wkly Rep
. 2021 Dec;
70(49):1700-1705.
PMID: 34882654
The mRNA COVID-19 vaccines (Moderna and Pfizer-BioNTech) provide strong protection against severe COVID-19, including hospitalization, for at least several months after receipt of the second dose (1,2). However, studies examining...
8.
Lim T, Delorey M, Bestul N, Johannson M, Reed C, Hall A, et al.
Clin Infect Dis
. 2021 Feb;
73(10):1831-1839.
PMID: 33639620
Background: Monitoring of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence can complement case reporting to inform more accurate estimates of SARS-CoV-2 infection burden, but few studies have undertaken...
9.
Bajema K, Dahlgren F, Lim T, Bestul N, Biggs H, Tate J, et al.
Clin Infect Dis
. 2020 Dec;
73(9):e3120-e3123.
PMID: 33300579
We compared severe acute respiratory syndrome coronavirus 2 seroprevalence estimated from commercial laboratory residual sera and a community household survey in metropolitan Atlanta during April and May 2020 and found...
10.
Basavaraju S, Patton M, Grimm K, Rasheed M, Lester S, Mills L, et al.
Clin Infect Dis
. 2020 Nov;
72(12):e1004-e1009.
PMID: 33252659
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in December 2019, with subsequent worldwide spread. The...